OBJECTIVES: Obesity has been associated with worse postoperative outcomes. No data are available regarding short-term results after liver resection (LR). The aim of this study was to analyse outcomes in obese patients (body mass index [BMI] > 30 kg/m(2) ) undergoing LR. METHODS: 85 consecutive obese patients undergoing LR between 1998 and 2008 were matched on a ratio of 1:2 with 170 non-obese patients. Matching criteria were diagnosis, ASA score, METAVIR fibrosis score, extent of LR, and Child-Pugh score in patients with cirrhosis. RESULTS: Operative time, blood loss and blood transfusions were similar in the two groups. Mortality was 2.4% in both groups. Morbidity was significantly higher in the obese group (32.9% vs. 21.2%; P= 0.041). However, only grade II morbidity was increased in obese patients (14.1% vs. 1.8%; P < 0.001) and this was mainly related to abdominal wall complications (8.2% vs. 2.4%; P= 0.046). No differences were encountered in terms of grade III or IV morbidity. The same results were observed in major LR and cirrhotic patients. When patients were stratified by BMI (<20, 20-25, 25-30 and >30 kg/m(2) ), progressive increases in overall and infectious morbidity were observed (5.6%, 22.4%, 23.7%, 32.9%, and 5.6%, 11.8%, 14.5%, 18.8%, respectively). Rates of grade III and IV morbidity did not change. DISCUSSION: Obese patients have increased postoperative morbidity after LR in comparison with non-obese patients, but this is mainly related to minor abdominal wall complications. Severe morbidity rates and mortality are similar to those in non-obese patients, even in cirrhosis or after major LR.
OBJECTIVES: Obesity has been associated with worse postoperative outcomes. No data are available regarding short-term results after liver resection (LR). The aim of this study was to analyse outcomes in obesepatients (body mass index [BMI] > 30 kg/m(2) ) undergoing LR. METHODS: 85 consecutive obesepatients undergoing LR between 1998 and 2008 were matched on a ratio of 1:2 with 170 non-obesepatients. Matching criteria were diagnosis, ASA score, METAVIR fibrosis score, extent of LR, and Child-Pugh score in patients with cirrhosis. RESULTS: Operative time, blood loss and blood transfusions were similar in the two groups. Mortality was 2.4% in both groups. Morbidity was significantly higher in the obese group (32.9% vs. 21.2%; P= 0.041). However, only grade II morbidity was increased in obesepatients (14.1% vs. 1.8%; P < 0.001) and this was mainly related to abdominal wall complications (8.2% vs. 2.4%; P= 0.046). No differences were encountered in terms of grade III or IV morbidity. The same results were observed in major LR and cirrhoticpatients. When patients were stratified by BMI (<20, 20-25, 25-30 and >30 kg/m(2) ), progressive increases in overall and infectious morbidity were observed (5.6%, 22.4%, 23.7%, 32.9%, and 5.6%, 11.8%, 14.5%, 18.8%, respectively). Rates of grade III and IV morbidity did not change. DISCUSSION: Obesepatients have increased postoperative morbidity after LR in comparison with non-obesepatients, but this is mainly related to minor abdominal wall complications. Severe morbidity rates and mortality are similar to those in non-obesepatients, even in cirrhosis or after major LR.
Authors: Timothy K Williams; Ernest L Rosato; Eugene P Kennedy; Karen A Chojnacki; Jocelyn Andrel; Terry Hyslop; Cataldo Doria; Patricia K Sauter; Jordan Bloom; Charles J Yeo; Adam C Berger Journal: J Am Coll Surg Date: 2008-12-18 Impact factor: 6.113
Authors: Lucas McCormack; Henrik Petrowsky; Wolfram Jochum; Katarzyna Furrer; Pierre-Alain Clavien Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Johan Friso Lock; Maciej Malinowski; Daniel Seehofer; Steffi Hoppe; Rhea Isabel Röhl; Stefan Markus Niehues; Peter Neuhaus; Martin Stockmann Journal: Langenbecks Arch Surg Date: 2012-06-24 Impact factor: 3.445
Authors: Neil H Bhayani; Omar Hyder; Wayne Frederick; Richard D Schulick; Christopher L Wolgang; Kenzo Hirose; Barish Edil; Joseph M Herman; Michael A Choti; Timothy M Pawlik Journal: Surgery Date: 2012-08 Impact factor: 3.982
Authors: Toine M Lodewick; Thiemo J A van Nijnatten; Ronald M van Dam; Kim van Mierlo; Simon A W G Dello; Ulf P Neumann; Steven W M Olde Damink; Cornelis H C Dejong Journal: HPB (Oxford) Date: 2014-12-16 Impact factor: 3.647
Authors: Marco Massani; Giovanni Capovilla; Cesare Ruffolo; Roberta Bonariol; Paola Maccatrozzo; Francesco Tuci; Giuseppe Battistella; Gian Luca Grazi; Nicolò Bassi Journal: Mol Clin Oncol Date: 2017-08-01